Subutex and Zopiclone drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 107 people who take Subutex and Zopiclone. Common interactions include somnolence among females, and somnolence among males.
The phase IV clinical study analyzes what interactions people who take Subutex and Zopiclone have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
107 people who take Subutex and Zopiclone together, and have interactions are studied.
What is Subutex?
Subutex has active ingredients of buprenorphine hydrochloride. It is used in opiate withdrawal. Currently, eHealthMe is studying from 8,593 Subutex users.
What is Zopiclone?
Zopiclone has active ingredients of eszopiclone. It is used in insomnia. Currently, eHealthMe is studying from 49,246 Zopiclone users.
Number of Subutex and Zopiclone reports submitted per year:
Subutex and Zopiclone drug interactions by gender *:
Subutex and Zopiclone drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Subutex and Zopiclone?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
Drug side effects by duration, gender and age:
Common Subutex drug interactions:
- Subutex and Suboxone: 2,084 reports
- Subutex and Oxycontin: 620 reports
- Subutex and Hydrocodone bitartrate and acetaminophen: 486 reports
- Subutex and Nicotine: 477 reports
- Subutex and Xanax: 336 reports
- Subutex and Dilaudid: 317 reports
- Subutex and Valium: 316 reports
- Subutex and Diazepam: 310 reports
- Subutex and Tramadol: 303 reports
- Subutex and Morphine: 276 reports
Browse interactions between Subutex and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Zopiclone drug interactions:
- Zopiclone and Pantoprazole: 7,578 reports
- Zopiclone and Prednisone: 7,181 reports
- Zopiclone and Methotrexate: 4,628 reports
- Zopiclone and Furosemide: 4,547 reports
- Zopiclone and Acetaminophen: 4,268 reports
- Zopiclone and Omeprazole: 3,917 reports
- Zopiclone and Sertraline: 3,887 reports
- Zopiclone and Amlodipine: 3,883 reports
- Zopiclone and Paracetamol: 3,746 reports
- Zopiclone and Clonazepam: 3,745 reports
Browse interactions between Zopiclone and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on buprenorphine hydrochloride and eszopiclone (the active ingredients of Subutex and Zopiclone, respectively), and Subutex and Zopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Subutex and Zopiclone.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Platinol-Aq and Taxotere drug interaction - 11 seconds ago
- Toradol and Stelazine drug interaction - 42 seconds ago
- Depo-Provera and Rebif drug interaction - a minute ago
- Jakafi and Transderm Scop drug interaction - a minute ago
- Penicillin and Doxycycline drug interaction - a minute ago
- Amlodipine Besylate and Blood Alkaline Phosphatase Increased - a minute ago
- Femara and Hyponatremia - 2 minutes ago
- Zovirax and Bronchopleural Fistula - 2 minutes ago
- Triamterene And Hydrochlorothiazide and Arava drug interaction - 3 minutes ago
- Topamax and Jaundice - Yellow Skin - 3 minutes ago